Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
ยฃ0.46 B
Marketcap
ยฃ13.29
Share price
-0.91%
Change (1 day)
-47.68%
Change (1 year)

Earnings for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

Earnings in 2026 (TTM): ยฃ24.74 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are ยฃ0.13 Billion. In 2025 the company made an earning of ยฃ22.11 Million, an increase over its 2024 earnings that were of ยฃ18.55 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ24.74 M11.88%
2025 ยฃ22.11 M19.18%
2024 ยฃ18.55 M16.26%
2023 ยฃ15.96 M